Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Rectal Neoplasms 14Colorectal Neoplasms 14Colonic Neoplasms 14Stomach Neoplasms 10Ovarian Neoplasms 6Carcinoma, Hepatocellular 5Gastrointestinal Stromal Tumors 4Carcinoma, Renal Cell 4Pancreatic Neoplasms 3Liver Neoplasms 3Peritoneal Neoplasms 2Neoplastic Cells, Circulating 2Neoplasms 2Kidney Neoplasms 2Fallopian Tube Neoplasms 2Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Endometrial Neoplasms 2Carcinoma, Ovarian Epithelial 2Uterine Cervical Neoplasms 1Urinary Incontinence 1Surgical Wound Infection 1Sexual Dysfunction, Physiological 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Pancreatic Neuroendocrine Tumors 1Ovarian Cysts 1Obesity, Morbid 1Neoplasm Metastasis 1Myofibroma 1

Interventions

Trastuzumab 594Paclitaxel 561Cyclophosphamide 545Docetaxel 478Capecitabine 387Letrozole 350Fulvestrant 310Doxorubicin 285Carboplatin 277Tamoxifen 257Anastrozole 219exemestane 211Epirubicin 210Radiotherapy 197Bevacizumab 189pertuzumab 175Gemcitabine 163Vinorelbine 162pembrolizumab 161Lapatinib 161palbociclib 152Exercise 132Fluorouracil 118Albumin-Bound Paclitaxel 116eribulin 108Magnetic Resonance Spectroscopy 108130-nm albumin-bound paclitaxel 107Everolimus 103Taxes 96Cisplatin 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Breast Neoplasms × Laparoscopy × Clear all
NCT00002580 2013-11-06

Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer

National Cancer Institute (NCI)

Phase 3 Completed
1,000 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡